These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17596574)

  • 21. [A case of osteonecrosis of the lower jaw due to bisphosphonates in a breast cancer patient with bone metastasis].
    Kubo N; Katayama K; Ishizaki A; Morinaga N; Negishi T; Kuwano H
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1973-5. PubMed ID: 19011355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study.
    Vestergaard P; Schwartz K; Rejnmark L; Mosekilde L; Pinholt EM
    J Oral Maxillofac Surg; 2012 Apr; 70(4):821-9. PubMed ID: 21764202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?
    Diel IJ; Fogelman I; Al-Nawas B; Hoffmeister B; Migliorati C; Gligorov J; Väänänen K; Pylkkänen L; Pecherstorfer M; Aapro MS
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):198-207. PubMed ID: 17855108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteonecrosis of the jaw and bisphosphonates--putting the risk in perspective.
    Bolland M; Hay D; Grey A; Reid I; Cundy T
    N Z Med J; 2006 Dec; 119(1246):U2339. PubMed ID: 17151713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteonecrosis of the jaw: a rare and devastating side effect of bisphosphonates.
    Ryan P; Saleh I; Stassen LF
    Postgrad Med J; 2009 Dec; 85(1010):674-7. PubMed ID: 20075406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
    Abu-Id MH; Warnke PH; Gottschalk J; Springer I; Wiltfang J; Acil Y; Russo PA; Kreusch T
    J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder.
    Dannemann C; Grätz KW; Riener MO; Zwahlen RA
    Bone; 2007 Apr; 40(4):828-34. PubMed ID: 17236837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
    Gering A; Grange L; Villier C; Woeller A; Mallaret M
    Therapie; 2007; 62(1):49-54. PubMed ID: 17374348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteonecrosis of the jaw due to bisphosphonates.
    Prescrire Int; 2008 Oct; 17(97):202-3. PubMed ID: 19536938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
    Lazarovici TS; Yahalom R; Taicher S; Elad S; Hardan I; Yarom N
    J Oral Maxillofac Surg; 2009 Apr; 67(4):850-5. PubMed ID: 19304045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: a Belgian case series.
    Saussez S; Javadian R; Hupin C; Magremanne M; Chantrain G; Loeb I; Decaestecker C
    Laryngoscope; 2009 Feb; 119(2):323-9. PubMed ID: 19172621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical comparison of patients with osteonecrosis of the jaws, with and without a history of bisphosphonates administration.
    Kos M; Brusco D; Kuebler J; Engelke W
    Int J Oral Maxillofac Surg; 2010 Nov; 39(11):1097-102. PubMed ID: 20817480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Osteonecrosis of the jaw associated with the use of bisphosphonates in multiple myeloma: report of four cases and literature review].
    Li LH; Wu XB; Chen WM; Chen JX; Wu Y; Chen SL
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2986-7. PubMed ID: 19080077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteonecrosis of the jaw associated with pamidronate therapy.
    Zarychanski R; Elphee E; Walton P; Johnston J
    Am J Hematol; 2006 Jan; 81(1):73-5. PubMed ID: 16369966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the bone.
    Cremers S; Farooki A
    Ann N Y Acad Sci; 2011 Feb; 1218():80-7. PubMed ID: 20946577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
    García Sáenz JA; López Tarruella S; García Paredes B; Rodríguez Lajusticia L; Villalobos L; Díaz Rubio E
    Med Oral Patol Oral Cir Bucal; 2007 Sep; 12(5):E351-6. PubMed ID: 17767097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.